Aarey Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2026 ,inter alia, to consider and approve This is to intimate ....
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarey Drugs & Pharmaceuticals has informed BSE that its Board of Directors will meet on Wednesday, 11th February 2026. The main agenda is to consider and approve the Unaudited Financial Results along with the Limited Review Report for the quarter ended 31st December 2025 (Q3 FY26). The meeting also has a standard agenda item allowing discussion of any other matter with the Chairman's consent. The company's trading window has been closed from 1st January 2026 and will remain closed until 48 hours after the results are announced, in line with SEBI insider trading norms.
This is a routine regulatory filing with no direct impact on stock price. Investors should monitor the actual Q3 FY26 results announcement on 11th February 2026 for any meaningful business or financial updates.